Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease

This publication has 15 references indexed in Scilit:

• An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)
  Nephrology Dialysis Transplantation, 2001
• Optimization of pre-ESRD care: The key to improved dialysis outcomes
  Kidney International, 2000
• Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic Patients
  Nephron, 1997
• Quality of life in predialytic uremic patients
  Quality of Life Research, 1996
• Blood Pressure Control, Proteinuria, and the Progression of Renal Disease
  Annals of Internal Medicine, 1995
• Pharmacokinetics of Recombinant Human Erythropoietin in Children with Renal Failure
  Nephrology Dialysis Transplantation, 1991
• The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
  Kidney International, 1989
• Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1987
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• The Role of Carbohydrate in Erythropoietin Action*
  Endocrinology, 1985